Evidence map›Paper›PMID 41526532›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Fabrication of size-tunable polydopamine nanoparticles: toxicity evaluation in cellular and animal models.

Rumi Mahata, Sujata Maiti Choudhury

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rumi MahataCancer Nanotherapeutics and Toxicology Research Laboratory, Biochemistry, Molecular Endocrinology, and Reproductive Physiology Division, Department of Human Physiology, Vidyasagar University, Midnapore, 721102, West Bengal, India.
Sujata Maiti ChoudhuryCancer Nanotherapeutics and Toxicology Research Laboratory, Biochemistry, Molecular Endocrinology, and Reproductive Physiology Division, Department of Human Physiology, Vidyasagar University, Midnapore, 721102, West Bengal, India. sujata_vu@mail.vidyasagar.ac.in.

Funding

University Grants Commission 211610238352
6 · The paper itself

Abstract

Nanotechnologically synthesized polymeric nanoparticles are now utilized as promising drug carriers. The size of the nanoparticles is crucial for the effective development of a drug delivery regime since it significantly affects drug loading, in vivo drug pharmacokinetics, bio-distribution, and cellular uptake. We demonstrate the fabrication of polydopamine nanoparticles (PDA NPs) in different molar concentrations of ammonia to dopamine hydrochloride to tune a suitable size for their effective efficacy. Dynamic light scattering (DLS) and SEM characterizations revealed their size and morphology. The stability of the nanoparticles was improved upon lyophilization and storage at 4 °C. FTIR,

Indexed as

AntioxidantsDrug CarriersIndolesNanoparticlesPolymersAnimalsCell SurvivalFemaleHumansMaleMembrane Potential, MitochondrialMiceOxidative StressParticle SizeAntioxidantsDrug CarriersIndolespolydopaminePolymersIn vitro antioxidantMitochondrial membrane potentialOxidative stressPolydopaminePolymeric nanoparticleToxicity profiling

Identifiers

PMID41526532

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.